Back to Results
First PageMeta Content
Pharmaceuticals policy / Drug discovery / Epidemiology / Pharmaceutical industry / Orphan drug / Pharmaceutical Benefits Scheme / Rare disease / European Medicines Agency / Pharmacovigilance / Pharmaceutical sciences / Health / Pharmacology


Vertex’s response to the Public Consultation on the Postmarket Review of the Life Saving Drugs Programme Executive Summary In this submission, we set out Vertex’s response to the Post-Market Review of the Life Saving
Add to Reading List

Document Date: 2015-03-04 00:09:47


Open Document

File Size: 515,12 KB

Share Result on Facebook

Company

Wilson / Vertex / /

Continent

Australia / Europe / /

Country

Taiwan / Germany / Netherlands / Italy / Northern Ireland / Sweden / New Zealand / Norway / France / Japan / Austria / United States / Australia / United Kingdom / Scotland / South Korea / Greece / Denmark / Wales / /

Currency

EUR / /

Event

FDA Phase / /

Holiday

Commonwealth Day / /

IndustryTerm

increased survival increases on-going healthcare costs / biotechnology / stretched healthcare budgets / life-saving products / pharmaceuticals / /

MedicalCondition

rare diseases / certain diseases / wake disorder / HAE / hereditary angioedema / neurogenic orthostatic hypotension / cystic fibrosis / very rare diseases / common diseases / less prevalent diseases / serious diseases / lipodystrophy / Haemophilia A / disease / NSCLC / rare disease / Haemophilia B / Gaucher Disease / serious and life-threatening diseases / rare disorders / diseases / only very rare diseases / Multicentric Castleman’s disease / syndrome / disorders / /

MedicalTreatment

chemo / /

Organization

Dept of Health / Therapeutic Goods Administration / Rare Conditions Medicines Fund / European Medicines Agency / South Korea’s Ministry of Food and Drug Safety / US Food and Drug Administration / FDA / European Union / Department of Health / New Medicines Fund / Ministry of Health / /

Person

EMA US FDA / /

Position

Governor / Life Saving Drugs Programme Executive / /

Product

propranolol hydrochloride / OptumRx - Drug / Public Drug / G551D / /

PublishedMedium

the Postmarket Review / /

Region

South Korea / /

Technology

biotechnology / http / drug development / /

URL

http /

SocialTag